The trade has been doing extremely well and is halfway through to the first target of 16800.
In the short run, the trade is also supported by fundamental factors. The rupee has weakened recently and the outlook for it isn't great. Indian pharma sector, which is primarily driven by exports, gains as the rupee weakens further.
The log run target still remains 19000, so still plenty of upside for investors looking to join in.
Good luck!